Venous Thromboembolism (DVT & PE)
VTE High-yield Verified · Sep 2026Venous thromboembolism (VTE) is the disease spectrum in which a blood clot forms in a deep vein — usually of the leg (deep vein thrombosis, DVT) — and can break loose and travel to block a lung artery (pulmonary embolism, PE).
The disorder behind Virchow’s triad, the no-massage rule, calf-circumference measurement, the D-dimer rule-out, and the bleeding-precautions talk — and the reason compression devices hum on every post-op unit.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Virchow’s triad — three roads to one clot
DVT is the third most common cause of cardiovascular death after heart attack and stroke, striking 1–2 people per 1,000 each year (≈ 300,000–600,000 US events); risk climbs with age, mostly in the over-40 group. Rudolf Virchow described the three factors that predispose to it back in 1856, and they still organize every risk factor you will ever memorize: stasis (slowed or altered blood flow), endothelial injury (damage to the vessel lining), and hypercoagulability (blood that clots too readily).
Each arm has faces you will recognize on the unit. Stasis: the bedridden patient, the long flight, surgery under general anesthesia, atrial fibrillation, a poorly contracting ventricle, a tumor compressing a vein. Endothelial injury: surgery and trauma, IV and PICC catheters, a previous DVT, smoking, chronic hypertension. The healthy endothelium is actively anticoagulant — surface proteins like thrombomodulin keep clotting in check — and injury sheds those molecules, tipping the wall pro-coagulant. Hypercoagulability: malignancy (tumors shed tissue factor), oral contraceptives — with obesity acting synergistically — inherited variants like factor V Leiden, sepsis, dehydration, and pregnancy. Pregnancy actually touches all three arms: progesterone dilates veins (stasis), circulating cytokines erode the endothelial layer (injury), and clotting factors rise while fibrinolysis falls (hypercoagulability).
The classic hospital patient stacks arms. Surgery under general anesthesia and the immobility around it open the window, and prophylaxis continues until the patient is ambulatory — which is why the most commonly associated hospital conditions are surgery, malignancy, heart failure, and obstructive airway disease, and why prevention is a nursing job from admission onward.
02 Where the clot is born — and how it grows
Venous thrombi are born in the slowest water: the soleal sinuses of the calf and the pockets behind venous valves, where flow eddies and stalls. In that stagnant pocket, local hypoxia activates the endothelium — the valve-pocket lining downregulates its protective anticoagulant proteins (thrombomodulin, endothelial protein C receptor) and expresses P-selectin, an adhesion molecule that recruits immune cells carrying tissue factor. The young thrombus then interacts with the endothelium itself, stimulating cytokine production and leukocyte adhesion — and the clot propagates.
The thrombus typically begins below the knee and extends proximally, the direction set by the running balance between the coagulation and thrombolytic pathways. Crucially, symptoms appear only when the clot has grown enough to obstruct venous flow — which is why so many DVTs smolder silently. Under the microscope, the venous clot is an inner platelet-rich white core (the lines of Zahn) wrapped in a red-cell-dense fibrin clot — and that architecture is the pharmacology lesson. Platelets dominate arterial thrombosis, which is why antiplatelets rule arterial disease; venous thrombosis is a coagulation-cascade, fibrin problem, which is why VTE is treated with anticoagulants that target procoagulant factors.
03 The embolization bridge — when DVT becomes PE
A DVT is dangerous less for where it is than for where it can go. If the clot dislodges from the vein wall, it rides the venous return through the right heart and lodges in the pulmonary vasculature — the most common destination — where it obstructs flow and impairs gas exchange, causing alveolar edema and even alveolar necrosis. Most PEs start exactly this way: one study found DVT in 70% of patients with proven PE. (With an atrial septal defect, a venous clot can even cross into the systemic circulation — a paradoxical embolism.)
This mechanism is the reason behind a family of nursing rules. Avoid massaging the leg with a suspected or confirmed DVT — deep massage can break the clot loose, and a fatal PE after leg massage has been reported; Homan’s-sign testing is retired as unreliable; and an acute DVT contraindicates mechanical compression on that leg. The stakes justify the caution: PE is the most common preventable cause of in-hospital death, and about 30% of untreated PE patients die versus 8% with timely therapy — the sudden-dyspnea call is a race.
04 Provoked, unprovoked — and why the label matters
Every VTE gets sorted by what caused it, because the label sets the length of treatment. Provoked by a transient factor: surgery with general anesthesia (longer than 30 minutes qualifies), hospitalization longer than 72 hours, cesarean section, pregnancy and the peripartum period, hormone therapy, or a leg injury with more than 72 hours of limited mobility. Provoked by a persistent factor: active cancer or ongoing inflammatory disease such as lupus or inflammatory bowel disease. Unprovoked: no identifiable trigger in either group.
The logic: a clot provoked by a transient factor carries a lower recurrence risk once the trigger is gone, so a defined course of anticoagulation (≈ 3–6 months) closes the case. A persistent trigger — or no identifiable trigger at all — means the clotting conditions remain, so long-term therapy may be needed to prevent recurrence, and after a recurrent unprovoked VTE, ASH 2020 strongly recommends indefinite anticoagulation. Recurrence is no small threat — up to 25% — and about 6% of DVT and 12% of PE patients die within a month of diagnosis, so getting the duration right is not bookkeeping; it is the relapse-prevention plan.
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
The definitive VTE therapy — venous clots are coagulation-driven fibrin clots, so treatment targets procoagulant factors, aiming to prevent PE, recurrence, and post-thrombotic syndrome. The concept exams love: anticoagulation does not dissolve the existing clot — it stops propagation while the body’s own fibrinolysis clears it. ASH 2020 suggests DOACs over warfarin (INR 2.0–3.0 where warfarin is used); LMWH is the preferred anticoagulant in pregnancy (StatPearls), and duration is set by provoked-vs-unprovoked status.
Mostly what VTE is not treated with: platelets dominate arterial thrombosis, so antiplatelets are the cornerstone there — not in fibrin-rich venous clots. Even for prophylaxis, aspirin alone is not generally recommended — it beats placebo but has not been compared with the heparins; its niche is hybrid therapy, taking over at discharge after other agents are used in hospital.
Beyond medications
- Early ambulation — the nurse-owned prophylaxis: encourage early ambulation, or frequent leg exercises for post-op and bed-bound patients. Thromboprophylaxis cuts VTE incidence by 30–65%, yet only about half of at-risk hospitalized patients receive it.
- Mechanical prophylaxis — graduated compression stockings, intermittent pneumatic compression, venous foot pumps — used with pharmacologic prophylaxis, not instead of it (StatPearls: pharmacologic prophylaxis is preferred, with or without mechanical methods). It is the only route when bleeding bars drugs (active bleeding, platelets < 50,000, hemorrhagic coagulopathy, neuraxial catheter); contraindicated over limb ischemia or skin breakdown — and never on a limb with an existing DVT.
- Elevation & moist heat for the affected limb reduce swelling and discomfort — elevation is not massage and does not conflict with the no-massage rule. After a DVT: below-knee graduated compression stockings (> 23 mm Hg) for 2 years if not contraindicated.
- Catheter-directed thrombolysis / thrombectomy — a narrow niche: symptomatic iliofemoral DVT, symptoms < 14 days, good functional status, life expectancy ≥ 1 year, low bleeding risk. ASH 2020 strongly recommends thrombolytic therapy for PE with hemodynamic compromise.
- IVC filter — a last resort that traps emboli below the renal veins for patients with an absolute contraindication to, failure of, or complication from anticoagulation. It is not recommended in acute DVT, does not treat the clot, does not replace anticoagulation, may increase recurrent DVT, and shows no survival benefit — and many "retrievable" filters are never retrieved.
- Home treatment for uncomplicated DVT — ASH 2020 suggests home treatment over hospital-based treatment for uncomplicated DVT and PE at low risk for complications. Reasons to keep a patient in hospital instead include signs of higher risk (for PE, sPESI flags include heart rate ≥ 110, systolic BP < 100 mmHg and oxygen saturation < 90%, alongside age over 80, active cancer and chronic cardiopulmonary disease), comorbidities and a raised bleeding risk on anticoagulation, lack of social support or other nonmedical reasons for admission, and doubts about adherence or reliable access to anticoagulation and outpatient care.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
The cues that matter: unilateral right-calf swelling with warmth, redness, and deep-vein tenderness, a +3.5 cm calf-circumference difference, and a new "cramping" calf pain — in a patient stacked with risk (knee arthroplasty, age > 40, obesity, post-op immobility). The noise: T 37.1 °C and a mildly elevated HR. Note what is not protective: she received prophylaxis — prophylaxis reduces risk, it doesn’t abolish it.
- 2 Analyze cues
One swollen, warm, red, tender calf on POD 3 is DVT until proven otherwise. Her Wells items stack: major surgery within 12 weeks, localized deep-vein tenderness, calf > 3 cm larger, unilateral swelling — a high pretest probability. That routing matters: high probability means skip the D-dimer and go straight to duplex ultrasound — a D-dimer would be uninterpretable anyway, since recent surgery is a classic false positive.
- 3 Prioritize
The dangerous outcome is not the leg — it is embolization to the lungs. Priority one is therefore mechanical: no massage, and get the SCD off that leg. Priority two — right behind it — is escalation so urgent testing and anticoagulation start. The cramping pain itself is the least urgent item on the list.
- 4 Generate solutions
Decline the massage — with an explanation, not just a "no." Elevate the right leg; remove the SCD sleeve from the right leg; then immediately notify the surgeon with an SBAR anticipating an urgent duplex ultrasound and therapeutic anticoagulation. Put the PE cue cluster on everyone’s radar.
- 5 Take action
Act, then call at once: leg elevated, right SCD off — neither needs an order. Then the SBAR: "POD 3 right TKA on prophylactic enoxaparin: new unilateral right-calf swelling, warmth, erythema, deep-vein tenderness, calf 3.5 cm larger than the left at marked sites. I’ve elevated the leg and removed the right SCD. Requesting evaluation — anticipate duplex ultrasound and anticoagulation orders." The trap to avoid: rubbing the calf to "work out the cramp" — deep massage of a leg with a DVT can break the clot loose.
- 6 Evaluate
Success in the next hours: duplex done and results acted on; if positive — anticoagulation started, aPTT/INR monitoring per agent, bleeding watch running; swelling receding with elevation. The re-escalation trigger is memorized in advance: sudden dyspnea, pleuritic chest pain, tachycardia, hemoptysis, or syncope = embolization — an emergency, not a page for the morning rounds.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
A 66-year-old woman, POD 3 after right total knee arthroplasty. History: obesity, hypertension. Orders: daily prophylactic enoxaparin, sequential compression devices (SCDs) bilaterally, up with PT twice daily. She calls you over: "My right calf has been cramping all morning — could you rub it for me?"
Q1 Select all that apply Which assessment findings require follow-up? Select all that apply. - A. Right calf circumference 3.5 cm larger than the left
- B. New cramping right-calf pain that began this morning
- C. Right calf warm and reddened compared with the left
- D. Temperature 37.1 °C
- E. Platelet count 212 (baseline 234)
Reveal answer & rationale
Q2 Multiple choice The patient asks the nurse to massage her aching calf. The best action is to: - A. Gently massage the calf to relieve the muscle cramp
- B. Explain that massage must be avoided because it could dislodge a clot, and assess the leg further
- C. Dorsiflex the foot to check for Homan’s sign before deciding
- D. Reposition the SCD sleeve higher on the calf to compress the painful area
Reveal answer & rationale
Q3 Put in order Put the nurse’s first four actions in priority order: - A. Notify the surgeon (SBAR), anticipating a duplex ultrasound and anticoagulation orders
- B. Decline the massage and elevate the right leg
- C. Remove the SCD sleeve from the right leg
- D. Document the findings and the updated plan of care
Reveal answer & rationale
Q4 Multiple choice At 1640 the patient suddenly reports shortness of breath and chest pain that worsens with a deep breath. HR is 118. These findings most likely indicate: - A. Anxiety about the possible diagnosis
- B. Atelectasis from postoperative immobility
- C. Embolization of the clot to the lungs — a medical emergency
- D. Expected post-surgical incisional pain radiating upward
Reveal answer & rationale
Q5 Multiple choice Duplex ultrasound confirms a DVT and anticoagulation is started. The patient says, "Good — this medicine will dissolve the clot." The best response is: - A. "Yes — it breaks the clot down over the next several days."
- B. "No — it stops the clot from growing and prevents pieces from traveling to your lungs while your body clears it."
- C. "No — only surgery can remove a clot once it has formed."
- D. "It thins the blood so the clot can pass through your veins harmlessly."
Reveal answer & rationale
Common questions
What causes venous thromboembolism (dvt & pe)?
What are the early signs of venous thromboembolism (dvt & pe)?
Which findings should a nurse report immediately in venous thromboembolism (dvt & pe)?
Why should you avoid massaging a leg with a suspected DVT?
Is Homan’s sign a reliable way to check for DVT?
How long does anticoagulation last after a DVT?
Sources
- ASH 2020 guidelines for management of VTE: treatment of DVT and PE — PubMed abstract — PubMed (National Library of Medicine)
- Deep Venous Thrombosis — StatPearls — StatPearls (NCBI Bookshelf)
- Virchow Triad — StatPearls — StatPearls (NCBI Bookshelf)
- D-Dimer Test — StatPearls — StatPearls (NCBI Bookshelf)
- ASH 2020 Guidelines for Management of VTE: Treatment of DVT and PE (Ortel et al.) — American Society of Hematology / Blood Advances (PMC)
- Deep Vein Thrombosis — MedlinePlus — MedlinePlus (NLM)
- Pulmonary Embolism — MedlinePlus — MedlinePlus (NLM)
- Open RN Health Alterations — Ch. 5 Cardiovascular Alterations (Deep Vein Thrombosis) — Open RN (NCBI Bookshelf)
- Patient Information Page: A guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism — Vascular Medicine (PMC, CC BY 4.0)
- Warfarin Sodium Tablets — Prescribing Information & Medication Guide — DailyMed (NLM)
- Deep Venous Thrombosis Prophylaxis — StatPearls — StatPearls (NCBI Bookshelf)
- Acute Pulmonary Embolism — StatPearls (PESI risk classes and outpatient suitability) — StatPearls (NCBI Bookshelf)
- Adherence and barriers to early discharge for patients with low-risk pulmonary embolism at a Latin American tertiary center (J Int Med Res 2026) — Journal of International Medical Research (SAGE, via PMC)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.